{"transactions":[{"id":2091819,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-10T00:41:23.000Z","date":"2022-12-06","kind":"exercise","acquired":false,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of issuer common stock upon settlement.  On December 6, 2022, the reporting person received 3,167 shares of issuer common stock in settlement of restricted stock units (RSUs)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest as as follows: 5,200 RSUs shall vest in three equal installments annually beginning on March 23, 2023; 1,664 RSUs shall vest in three equal installments annually beginning on September 29, 2022; 3,200 RSUs shall vest in two equal installments annually beginning on July 1, 2023; and 1,010 RSUs shall vest on March 30, 2023. Also includes 2,610 RSUs that were previously vested but were not settled until December 6, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs shall vest as as follows: 5,200 RSUs shall vest in three equal installments annually beginning on March 23, 2023; 1,664 RSUs shall vest in three equal installments annually beginning on September 29, 2022; 3,200 RSUs shall vest in two equal installments annually beginning on July 1, 2023; and 1,010 RSUs shall vest on March 30, 2023. Also includes 2,610 RSUs that were previously vested but were not settled until December 6, 2022."}],"balance_after":10517,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3167},"source":{"system":"sec-edgar","filing":"0001209191-22-060588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122060588/doc4.xml","form_type":"4"}},{"id":2091818,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-10T00:41:23.000Z","date":"2022-12-09","kind":"sale","acquired":false,"shares":320,"price":6.3121,"value":2019.872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations"}],"balance_after":3872,"source":{"system":"sec-edgar","filing":"0001209191-22-060588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122060588/doc4.xml","form_type":"4"}},{"id":2091817,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-10T00:41:23.000Z","date":"2022-12-06","kind":"sale","acquired":false,"shares":935,"price":4.9215,"value":4601.6025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.66 to $5.37, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth."}],"balance_after":4192,"source":{"system":"sec-edgar","filing":"0001209191-22-060588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122060588/doc4.xml","form_type":"4"}},{"id":2091816,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-10T00:41:23.000Z","date":"2022-12-06","kind":"exercise","acquired":true,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of issuer common stock upon settlement.  On December 6, 2022, the reporting person received 3,167 shares of issuer common stock in settlement of restricted stock units (RSUs)."}],"balance_after":5127,"source":{"system":"sec-edgar","filing":"0001209191-22-060588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122060588/doc4.xml","form_type":"4"}},{"id":3386931,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-29T20:56:05.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":36000,"price":2.75,"value":99000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the issuer's public offering."}],"balance_after":98000,"source":{"system":"sec-edgar","filing":"0001387131-19-007989","document":"bernick-form4_102519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119007989/bernick-form4_102519.xml","form_type":"4"}},{"id":3426493,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-31T01:48:58.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 100,000 shares on the first anniversary date of the grant, 100,000 shares on the second anniversary date of the grant, and 100,000 shares on the third anniversary date of the grant."}],"balance_after":300000,"derivative":{"exercise_price":2.73,"exercise_date":"2020-08-28","expiration_date":"2029-08-28","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001387131-19-006604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006604/ownership.xml","form_type":"4"}},{"id":3440631,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T20:31:43.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":10000,"price":2.87,"value":28700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $2.89, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4."}],"balance_after":62000,"source":{"system":"sec-edgar","filing":"0001387131-19-006033","document":"bernick-form4_080919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006033/bernick-form4_080919.xml","form_type":"4"}},{"id":3731685,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-15T01:01:52.000Z","date":"2018-12-13","kind":"exercise","acquired":false,"shares":91910,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91910},"source":{"system":"sec-edgar","filing":"0001387131-18-006797","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/ownership.xml","form_type":"4"}},{"id":3731684,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-15T01:01:52.000Z","date":"2018-12-12","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":91910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-006797","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/ownership.xml","form_type":"4"}},{"id":3731683,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-15T01:01:52.000Z","date":"2018-12-07","kind":"gift","acquired":false,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52000,"source":{"system":"sec-edgar","filing":"0001387131-18-006797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/ownership.xml","form_type":"4"}},{"id":3731682,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-15T01:01:52.000Z","date":"2018-12-13","kind":"sale","acquired":false,"shares":91910,"price":4.119,"value":378577.29,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.04 to $4.25, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-006797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/ownership.xml","form_type":"4"}},{"id":3731681,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-15T01:01:52.000Z","date":"2018-12-13","kind":"exercise","acquired":true,"shares":91910,"price":0.1018,"value":9356.438,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6649281,"source":{"system":"sec-edgar","filing":"0001387131-18-006797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/ownership.xml","form_type":"4"}},{"id":3731680,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-15T01:01:52.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":91400,"price":4.179,"value":381960.6,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.075 to $4.32, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-006797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/ownership.xml","form_type":"4"}},{"id":3731679,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-15T01:01:52.000Z","date":"2018-12-12","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-006797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/ownership.xml","form_type":"4"}},{"id":3745448,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-05T01:09:08.000Z","date":"2018-12-03","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":183310,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-006595","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006595/ownership.xml","form_type":"4"}},{"id":3745447,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-05T01:09:08.000Z","date":"2018-11-30","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":274710,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-006595","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006595/ownership.xml","form_type":"4"}},{"id":3745446,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-05T01:09:08.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":91400,"price":5.18,"value":473452.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.26, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-006595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006595/ownership.xml","form_type":"4"}},{"id":3745445,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-05T01:09:08.000Z","date":"2018-12-03","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-006595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006595/ownership.xml","form_type":"4"}},{"id":3745444,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-05T01:09:08.000Z","date":"2018-11-30","kind":"sale","acquired":false,"shares":91400,"price":4.96,"value":453344.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.9 to $5.045, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-006595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006595/ownership.xml","form_type":"4"}},{"id":3745443,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-05T01:09:08.000Z","date":"2018-11-30","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-006595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006595/ownership.xml","form_type":"4"}},{"id":3755908,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-22T00:01:44.000Z","date":"2018-11-20","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":366110,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-006362","document":"bernick-form4_111918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006362/bernick-form4_111918.xml","form_type":"4"}},{"id":3755907,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-22T00:01:44.000Z","date":"2018-11-19","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":457510,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-006362","document":"bernick-form4_111918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006362/bernick-form4_111918.xml","form_type":"4"}},{"id":3755906,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-22T00:01:44.000Z","date":"2018-11-20","kind":"sale","acquired":false,"shares":91400,"price":4.736,"value":432870.4,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.865, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-006362","document":"bernick-form4_111918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006362/bernick-form4_111918.xml","form_type":"4"}},{"id":3755905,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-22T00:01:44.000Z","date":"2018-11-20","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-006362","document":"bernick-form4_111918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006362/bernick-form4_111918.xml","form_type":"4"}},{"id":3755904,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-22T00:01:44.000Z","date":"2018-11-19","kind":"sale","acquired":false,"shares":91400,"price":4.747,"value":433875.8,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.665 to $4.88, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-006362","document":"bernick-form4_111918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006362/bernick-form4_111918.xml","form_type":"4"}},{"id":3755903,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-22T00:01:44.000Z","date":"2018-11-19","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-006362","document":"bernick-form4_111918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006362/bernick-form4_111918.xml","form_type":"4"}},{"id":3769140,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-14T01:01:31.000Z","date":"2018-11-09","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":548100,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-006131","document":"bernick-form4_110818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006131/bernick-form4_110818.xml","form_type":"4"}},{"id":3769139,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-14T01:01:31.000Z","date":"2018-11-08","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":640310,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-006131","document":"bernick-form4_110818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006131/bernick-form4_110818.xml","form_type":"4"}},{"id":3769138,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-14T01:01:31.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":91400,"price":4.826,"value":441096.4,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.925, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-006131","document":"bernick-form4_110818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006131/bernick-form4_110818.xml","form_type":"4"}},{"id":3769137,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-14T01:01:31.000Z","date":"2018-11-09","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-006131","document":"bernick-form4_110818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006131/bernick-form4_110818.xml","form_type":"4"}},{"id":3769136,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-14T01:01:31.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":91400,"price":4.926,"value":450236.4,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.6 to $5.05, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-006131","document":"bernick-form4_110818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006131/bernick-form4_110818.xml","form_type":"4"}},{"id":3769135,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-14T01:01:31.000Z","date":"2018-11-08","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-006131","document":"bernick-form4_110818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006131/bernick-form4_110818.xml","form_type":"4"}},{"id":3786226,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-22T23:19:39.000Z","date":"2018-10-19","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":731710,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-005562","document":"bernick-form4_101818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005562/bernick-form4_101818.xml","form_type":"4"}},{"id":3786225,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-22T23:19:39.000Z","date":"2018-10-18","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":823110,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-005562","document":"bernick-form4_101818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005562/bernick-form4_101818.xml","form_type":"4"}},{"id":3786224,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-22T23:19:39.000Z","date":"2018-10-19","kind":"sale","acquired":false,"shares":91400,"price":5.51,"value":503614.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.43 to $5.66, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-005562","document":"bernick-form4_101818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005562/bernick-form4_101818.xml","form_type":"4"}},{"id":3786223,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-22T23:19:39.000Z","date":"2018-10-19","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-005562","document":"bernick-form4_101818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005562/bernick-form4_101818.xml","form_type":"4"}},{"id":3786222,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-22T23:19:39.000Z","date":"2018-10-18","kind":"sale","acquired":false,"shares":91400,"price":5.61,"value":512754.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.48 to $5.87, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-005562","document":"bernick-form4_101818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005562/bernick-form4_101818.xml","form_type":"4"}},{"id":3786221,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-22T23:19:39.000Z","date":"2018-10-18","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-005562","document":"bernick-form4_101818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005562/bernick-form4_101818.xml","form_type":"4"}},{"id":3795627,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-09T23:00:45.000Z","date":"2018-10-05","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":914510,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-005357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005357/ownership.xml","form_type":"4"}},{"id":3795626,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-09T23:00:45.000Z","date":"2018-10-04","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":1005910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-005357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005357/ownership.xml","form_type":"4"}},{"id":3795625,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T23:00:45.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":91400,"price":5.93,"value":542002.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.855 to $6.045, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-005357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005357/ownership.xml","form_type":"4"}},{"id":3795624,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T23:00:45.000Z","date":"2018-10-05","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-005357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005357/ownership.xml","form_type":"4"}},{"id":3795623,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T23:00:45.000Z","date":"2018-10-04","kind":"sale","acquired":false,"shares":91400,"price":5.89,"value":538346.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.035, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-005357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005357/ownership.xml","form_type":"4"}},{"id":3795622,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T23:00:45.000Z","date":"2018-10-04","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-005357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005357/ownership.xml","form_type":"4"}},{"id":3805210,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-01T23:01:49.000Z","date":"2018-09-28","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":1097310,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-005141","document":"bernick-form4_092718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005141/bernick-form4_092718.xml","form_type":"4"}},{"id":3805209,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-01T23:01:49.000Z","date":"2018-09-27","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":1188710,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-005141","document":"bernick-form4_092718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005141/bernick-form4_092718.xml","form_type":"4"}},{"id":3805208,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T23:01:49.000Z","date":"2018-09-28","kind":"sale","acquired":false,"shares":91400,"price":6.549,"value":598578.6,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.44 to $6.735, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price\nwithin the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-005141","document":"bernick-form4_092718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005141/bernick-form4_092718.xml","form_type":"4"}},{"id":3805207,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T23:01:49.000Z","date":"2018-09-28","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-005141","document":"bernick-form4_092718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005141/bernick-form4_092718.xml","form_type":"4"}},{"id":3805206,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T23:01:49.000Z","date":"2018-09-27","kind":"sale","acquired":false,"shares":91400,"price":6.63,"value":605982.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.53 to $6.76, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-005141","document":"bernick-form4_092718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005141/bernick-form4_092718.xml","form_type":"4"}},{"id":3805205,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T23:01:49.000Z","date":"2018-09-27","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-005141","document":"bernick-form4_092718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005141/bernick-form4_092718.xml","form_type":"4"}},{"id":3816698,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-14T23:34:57.000Z","date":"2018-09-13","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together\nwith his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":1280110,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-004753","document":"bernick-form4_091218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004753/bernick-form4_091218.xml","form_type":"4"}},{"id":3816697,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-14T23:34:57.000Z","date":"2018-09-12","kind":"exercise","acquired":false,"shares":91400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together\nwith his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":1371510,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":91400},"source":{"system":"sec-edgar","filing":"0001387131-18-004753","document":"bernick-form4_091218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004753/bernick-form4_091218.xml","form_type":"4"}},{"id":3816696,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T23:34:57.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":91400,"price":6.345,"value":579933.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.43, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together\nwith his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-004753","document":"bernick-form4_091218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004753/bernick-form4_091218.xml","form_type":"4"}},{"id":3816695,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T23:34:57.000Z","date":"2018-09-13","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together\nwith his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-004753","document":"bernick-form4_091218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004753/bernick-form4_091218.xml","form_type":"4"}},{"id":3816694,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T23:34:57.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":91400,"price":6.255,"value":571707.0,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.34, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together\nwith his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6557371,"source":{"system":"sec-edgar","filing":"0001387131-18-004753","document":"bernick-form4_091218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004753/bernick-form4_091218.xml","form_type":"4"}},{"id":3816693,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T23:34:57.000Z","date":"2018-09-12","kind":"exercise","acquired":true,"shares":91400,"price":0.1018,"value":9304.52,"ownership":{"direct":false,"nature":"By BF Investment Enterprises, Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported securities are owned by BF Investment Enterprises, Ltd. (\"BF Investment\"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the \"GP\"), the general partner of BF Investment, (ii) holds, together\nwith his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6648771,"source":{"system":"sec-edgar","filing":"0001387131-18-004753","document":"bernick-form4_091218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004753/bernick-form4_091218.xml","form_type":"4"}},{"id":3991459,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-19T21:38:52.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 56,667 shares on the first anniversary date of the grant, 56,667 shares on the second anniversary date of the grant, and 56,666 shares on the third anniversary date of the grant."}],"balance_after":170000,"derivative":{"exercise_price":5.16,"exercise_date":"2019-03-15","expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001387131-18-001121","document":"bernick-form4_031518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118001121/bernick-form4_031518.xml","form_type":"4"}},{"id":4067890,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-13T02:14:51.000Z","date":"2017-11-30","kind":"gift","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":242000,"source":{"system":"sec-edgar","filing":"0001387131-18-000564","document":"bernick-form5_123117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118000564/bernick-form5_123117.xml","form_type":"5"}},{"id":4381758,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2017-03-17T22:34:50.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 56,667 shares on the first anniversary date of the grant, 56,667 shares on the second anniversary date of the grant, and 56,666 shares on the third anniversary date of the grant."}],"balance_after":170000,"derivative":{"exercise_price":6.83,"exercise_date":"2018-03-15","expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001387131-17-001461","document":"bernick-form4_031517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117001461/bernick-form4_031517.xml","form_type":"4"}},{"id":4453010,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":121758,"kind":"person","name":"Bernick Brian","position":1,"cik":"0001532233","reported_name":"Bernick Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T22:57:56.000Z","date":"2016-12-27","kind":"gift","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":267000,"source":{"system":"sec-edgar","filing":"0001387131-17-000845","document":"brian_bernick-form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117000845/brian_bernick-form5.xml","form_type":"5"}}]}